Anti‐Proliferative Activity of Poloxamer Cobalt Ferrite Nanoparticles against Human Prostate Cancer (DU‐145) Cells: In‐Vitro Study Article Swipe
Nazanin Oroskhani
,
Seyed Mohammad Amini
,
Sakine Shirvalilou
,
Mehdi Khodaie
,
Seied Rabi Mahdavi
·
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1049/2024/8929168
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1049/2024/8929168
Prostate cancer is the second most frequent type of cancer death in men. This study refers to the novel hyperthermia application of poloxamer‐coated cobalt ferrite as a new approach for thermal eradication of DU‐145 human prostate cancerous cells under a radio frequency magnetic field (RF‐MF). The hydrothermal method was applied for the synthesis of cobalt ferrite nanoparticles. Then, the structure, size, and morphology of nanoparticle were characterized. The cytotoxicity of the synthesized nanoparticles and RF‐MF exposure on DU‐145 prostate cancer cells was investigated separately or in combination with colony formation methods and MTT [3‐(4,5‐Dimethylthiazol‐2‐yl)‐2,5‐Diphenyltetrazolium Bromide] assay. Transmission electron microscopy (TEM) confirmed the spherical morphology of nanoparticles with a size of 5.5 ± 2.6 nm. The temperature of cells treated with nanoparticles under RF‐MF reached 42.73 ± 0.2°C after 15 min. RF‐MF treatment or nanoparticles have not affected cell viability significantly. However, the combination of them eradicated 53% ± 4% of cancerous cells. In‐vitro hyperthermia was performed on human prostate cancer cells (DU‐145) with cobalt ferrite nanoparticles at specific concentrations that demonstrated a decrease in survival fraction based on colony formation assay compared to cells that were treated alone with nanoparticles or with RF‐MF.
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1049/2024/8929168
- OA Status
- gold
- Cited By
- 14
- References
- 40
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4395095630
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4395095630Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1049/2024/8929168Digital Object Identifier
- Title
-
Anti‐Proliferative Activity of Poloxamer Cobalt Ferrite Nanoparticles against Human Prostate Cancer (DU‐145) Cells: In‐Vitro StudyWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2024Year of publication
- Publication date
-
2024-01-01Full publication date if available
- Authors
-
Nazanin Oroskhani, Seyed Mohammad Amini, Sakine Shirvalilou, Mehdi Khodaie, Seied Rabi MahdaviList of authors in order
- Landing page
-
https://doi.org/10.1049/2024/8929168Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1049/2024/8929168Direct OA link when available
- Concepts
-
Hyperthermia, Nanoparticle, Prostate cancer, Materials science, Cytotoxicity, Viability assay, MTT assay, Magnetic nanoparticles, Cobalt, Cancer cell, In vitro, Nanotechnology, Biophysics, Chemistry, Medicine, Cancer, Biology, Internal medicine, Biochemistry, MetallurgyTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
14Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 9, 2024: 5Per-year citation counts (last 5 years)
- References (count)
-
40Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4395095630 |
|---|---|
| doi | https://doi.org/10.1049/2024/8929168 |
| ids.doi | https://doi.org/10.1049/2024/8929168 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/39144409 |
| ids.openalex | https://openalex.org/W4395095630 |
| fwci | 4.91404548 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D006801 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Humans |
| mesh[1].qualifier_ui | |
| mesh[1].descriptor_ui | D008297 |
| mesh[1].is_major_topic | False |
| mesh[1].qualifier_name | |
| mesh[1].descriptor_name | Male |
| mesh[2].qualifier_ui | Q000737 |
| mesh[2].descriptor_ui | D003035 |
| mesh[2].is_major_topic | True |
| mesh[2].qualifier_name | chemistry |
| mesh[2].descriptor_name | Cobalt |
| mesh[3].qualifier_ui | Q000494 |
| mesh[3].descriptor_ui | D003035 |
| mesh[3].is_major_topic | True |
| mesh[3].qualifier_name | pharmacology |
| mesh[3].descriptor_name | Cobalt |
| mesh[4].qualifier_ui | Q000473 |
| mesh[4].descriptor_ui | D011471 |
| mesh[4].is_major_topic | True |
| mesh[4].qualifier_name | pathology |
| mesh[4].descriptor_name | Prostatic Neoplasms |
| mesh[5].qualifier_ui | Q000188 |
| mesh[5].descriptor_ui | D011471 |
| mesh[5].is_major_topic | True |
| mesh[5].qualifier_name | drug therapy |
| mesh[5].descriptor_name | Prostatic Neoplasms |
| mesh[6].qualifier_ui | Q000737 |
| mesh[6].descriptor_ui | D020442 |
| mesh[6].is_major_topic | True |
| mesh[6].qualifier_name | chemistry |
| mesh[6].descriptor_name | Poloxamer |
| mesh[7].qualifier_ui | Q000494 |
| mesh[7].descriptor_ui | D020442 |
| mesh[7].is_major_topic | True |
| mesh[7].qualifier_name | pharmacology |
| mesh[7].descriptor_name | Poloxamer |
| mesh[8].qualifier_ui | |
| mesh[8].descriptor_ui | D045744 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | |
| mesh[8].descriptor_name | Cell Line, Tumor |
| mesh[9].qualifier_ui | Q000737 |
| mesh[9].descriptor_ui | D005290 |
| mesh[9].is_major_topic | True |
| mesh[9].qualifier_name | chemistry |
| mesh[9].descriptor_name | Ferric Compounds |
| mesh[10].qualifier_ui | Q000494 |
| mesh[10].descriptor_ui | D005290 |
| mesh[10].is_major_topic | True |
| mesh[10].qualifier_name | pharmacology |
| mesh[10].descriptor_name | Ferric Compounds |
| mesh[11].qualifier_ui | Q000187 |
| mesh[11].descriptor_ui | D002470 |
| mesh[11].is_major_topic | True |
| mesh[11].qualifier_name | drug effects |
| mesh[11].descriptor_name | Cell Survival |
| mesh[12].qualifier_ui | Q000187 |
| mesh[12].descriptor_ui | D049109 |
| mesh[12].is_major_topic | True |
| mesh[12].qualifier_name | drug effects |
| mesh[12].descriptor_name | Cell Proliferation |
| mesh[13].qualifier_ui | Q000379 |
| mesh[13].descriptor_ui | D006979 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | methods |
| mesh[13].descriptor_name | Hyperthermia, Induced |
| mesh[14].qualifier_ui | Q000494 |
| mesh[14].descriptor_ui | D000970 |
| mesh[14].is_major_topic | False |
| mesh[14].qualifier_name | pharmacology |
| mesh[14].descriptor_name | Antineoplastic Agents |
| mesh[15].qualifier_ui | Q000737 |
| mesh[15].descriptor_ui | D000970 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | chemistry |
| mesh[15].descriptor_name | Antineoplastic Agents |
| mesh[16].qualifier_ui | Q000737 |
| mesh[16].descriptor_ui | D053768 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | chemistry |
| mesh[16].descriptor_name | Metal Nanoparticles |
| mesh[17].qualifier_ui | |
| mesh[17].descriptor_ui | D006801 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | |
| mesh[17].descriptor_name | Humans |
| mesh[18].qualifier_ui | |
| mesh[18].descriptor_ui | D008297 |
| mesh[18].is_major_topic | False |
| mesh[18].qualifier_name | |
| mesh[18].descriptor_name | Male |
| mesh[19].qualifier_ui | Q000737 |
| mesh[19].descriptor_ui | D003035 |
| mesh[19].is_major_topic | True |
| mesh[19].qualifier_name | chemistry |
| mesh[19].descriptor_name | Cobalt |
| mesh[20].qualifier_ui | Q000494 |
| mesh[20].descriptor_ui | D003035 |
| mesh[20].is_major_topic | True |
| mesh[20].qualifier_name | pharmacology |
| mesh[20].descriptor_name | Cobalt |
| mesh[21].qualifier_ui | Q000473 |
| mesh[21].descriptor_ui | D011471 |
| mesh[21].is_major_topic | True |
| mesh[21].qualifier_name | pathology |
| mesh[21].descriptor_name | Prostatic Neoplasms |
| mesh[22].qualifier_ui | Q000188 |
| mesh[22].descriptor_ui | D011471 |
| mesh[22].is_major_topic | True |
| mesh[22].qualifier_name | drug therapy |
| mesh[22].descriptor_name | Prostatic Neoplasms |
| mesh[23].qualifier_ui | Q000737 |
| mesh[23].descriptor_ui | D020442 |
| mesh[23].is_major_topic | True |
| mesh[23].qualifier_name | chemistry |
| mesh[23].descriptor_name | Poloxamer |
| mesh[24].qualifier_ui | Q000494 |
| mesh[24].descriptor_ui | D020442 |
| mesh[24].is_major_topic | True |
| mesh[24].qualifier_name | pharmacology |
| mesh[24].descriptor_name | Poloxamer |
| mesh[25].qualifier_ui | |
| mesh[25].descriptor_ui | D045744 |
| mesh[25].is_major_topic | False |
| mesh[25].qualifier_name | |
| mesh[25].descriptor_name | Cell Line, Tumor |
| mesh[26].qualifier_ui | Q000737 |
| mesh[26].descriptor_ui | D005290 |
| mesh[26].is_major_topic | True |
| mesh[26].qualifier_name | chemistry |
| mesh[26].descriptor_name | Ferric Compounds |
| mesh[27].qualifier_ui | Q000494 |
| mesh[27].descriptor_ui | D005290 |
| mesh[27].is_major_topic | True |
| mesh[27].qualifier_name | pharmacology |
| mesh[27].descriptor_name | Ferric Compounds |
| mesh[28].qualifier_ui | Q000187 |
| mesh[28].descriptor_ui | D002470 |
| mesh[28].is_major_topic | True |
| mesh[28].qualifier_name | drug effects |
| mesh[28].descriptor_name | Cell Survival |
| mesh[29].qualifier_ui | Q000187 |
| mesh[29].descriptor_ui | D049109 |
| mesh[29].is_major_topic | True |
| mesh[29].qualifier_name | drug effects |
| mesh[29].descriptor_name | Cell Proliferation |
| mesh[30].qualifier_ui | Q000379 |
| mesh[30].descriptor_ui | D006979 |
| mesh[30].is_major_topic | False |
| mesh[30].qualifier_name | methods |
| mesh[30].descriptor_name | Hyperthermia, Induced |
| mesh[31].qualifier_ui | Q000494 |
| mesh[31].descriptor_ui | D000970 |
| mesh[31].is_major_topic | False |
| mesh[31].qualifier_name | pharmacology |
| mesh[31].descriptor_name | Antineoplastic Agents |
| mesh[32].qualifier_ui | Q000737 |
| mesh[32].descriptor_ui | D000970 |
| mesh[32].is_major_topic | False |
| mesh[32].qualifier_name | chemistry |
| mesh[32].descriptor_name | Antineoplastic Agents |
| mesh[33].qualifier_ui | Q000737 |
| mesh[33].descriptor_ui | D053768 |
| mesh[33].is_major_topic | False |
| mesh[33].qualifier_name | chemistry |
| mesh[33].descriptor_name | Metal Nanoparticles |
| mesh[34].qualifier_ui | |
| mesh[34].descriptor_ui | D006801 |
| mesh[34].is_major_topic | False |
| mesh[34].qualifier_name | |
| mesh[34].descriptor_name | Humans |
| mesh[35].qualifier_ui | |
| mesh[35].descriptor_ui | D008297 |
| mesh[35].is_major_topic | False |
| mesh[35].qualifier_name | |
| mesh[35].descriptor_name | Male |
| mesh[36].qualifier_ui | Q000737 |
| mesh[36].descriptor_ui | D003035 |
| mesh[36].is_major_topic | True |
| mesh[36].qualifier_name | chemistry |
| mesh[36].descriptor_name | Cobalt |
| mesh[37].qualifier_ui | Q000494 |
| mesh[37].descriptor_ui | D003035 |
| mesh[37].is_major_topic | True |
| mesh[37].qualifier_name | pharmacology |
| mesh[37].descriptor_name | Cobalt |
| mesh[38].qualifier_ui | Q000473 |
| mesh[38].descriptor_ui | D011471 |
| mesh[38].is_major_topic | True |
| mesh[38].qualifier_name | pathology |
| mesh[38].descriptor_name | Prostatic Neoplasms |
| mesh[39].qualifier_ui | Q000188 |
| mesh[39].descriptor_ui | D011471 |
| mesh[39].is_major_topic | True |
| mesh[39].qualifier_name | drug therapy |
| mesh[39].descriptor_name | Prostatic Neoplasms |
| mesh[40].qualifier_ui | Q000737 |
| mesh[40].descriptor_ui | D020442 |
| mesh[40].is_major_topic | True |
| mesh[40].qualifier_name | chemistry |
| mesh[40].descriptor_name | Poloxamer |
| mesh[41].qualifier_ui | Q000494 |
| mesh[41].descriptor_ui | D020442 |
| mesh[41].is_major_topic | True |
| mesh[41].qualifier_name | pharmacology |
| mesh[41].descriptor_name | Poloxamer |
| mesh[42].qualifier_ui | |
| mesh[42].descriptor_ui | D045744 |
| mesh[42].is_major_topic | False |
| mesh[42].qualifier_name | |
| mesh[42].descriptor_name | Cell Line, Tumor |
| mesh[43].qualifier_ui | Q000737 |
| mesh[43].descriptor_ui | D005290 |
| mesh[43].is_major_topic | True |
| mesh[43].qualifier_name | chemistry |
| mesh[43].descriptor_name | Ferric Compounds |
| mesh[44].qualifier_ui | Q000494 |
| mesh[44].descriptor_ui | D005290 |
| mesh[44].is_major_topic | True |
| mesh[44].qualifier_name | pharmacology |
| mesh[44].descriptor_name | Ferric Compounds |
| mesh[45].qualifier_ui | Q000187 |
| mesh[45].descriptor_ui | D002470 |
| mesh[45].is_major_topic | True |
| mesh[45].qualifier_name | drug effects |
| mesh[45].descriptor_name | Cell Survival |
| mesh[46].qualifier_ui | Q000187 |
| mesh[46].descriptor_ui | D049109 |
| mesh[46].is_major_topic | True |
| mesh[46].qualifier_name | drug effects |
| mesh[46].descriptor_name | Cell Proliferation |
| mesh[47].qualifier_ui | Q000379 |
| mesh[47].descriptor_ui | D006979 |
| mesh[47].is_major_topic | False |
| mesh[47].qualifier_name | methods |
| mesh[47].descriptor_name | Hyperthermia, Induced |
| mesh[48].qualifier_ui | Q000494 |
| mesh[48].descriptor_ui | D000970 |
| mesh[48].is_major_topic | False |
| mesh[48].qualifier_name | pharmacology |
| mesh[48].descriptor_name | Antineoplastic Agents |
| mesh[49].qualifier_ui | Q000737 |
| mesh[49].descriptor_ui | D000970 |
| mesh[49].is_major_topic | False |
| mesh[49].qualifier_name | chemistry |
| mesh[49].descriptor_name | Antineoplastic Agents |
| type | article |
| title | Anti‐Proliferative Activity of Poloxamer Cobalt Ferrite Nanoparticles against Human Prostate Cancer (DU‐145) Cells: In‐Vitro Study |
| biblio.issue | 1 |
| biblio.volume | 2024 |
| biblio.last_page | 8929168 |
| biblio.first_page | 8929168 |
| grants[0].funder | https://openalex.org/F4320313199 |
| grants[0].award_id | 1400-2-68-20926 |
| grants[0].funder_display_name | Iran University of Medical Sciences |
| grants[1].funder | https://openalex.org/F4320313199 |
| grants[1].award_id | 1401-3-68-23796 |
| grants[1].funder_display_name | Iran University of Medical Sciences |
| topics[0].id | https://openalex.org/T10063 |
| topics[0].field.id | https://openalex.org/fields/25 |
| topics[0].field.display_name | Materials Science |
| topics[0].score | 0.9983999729156494 |
| topics[0].domain.id | https://openalex.org/domains/3 |
| topics[0].domain.display_name | Physical Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2502 |
| topics[0].subfield.display_name | Biomaterials |
| topics[0].display_name | Nanoparticle-Based Drug Delivery |
| topics[1].id | https://openalex.org/T10958 |
| topics[1].field.id | https://openalex.org/fields/22 |
| topics[1].field.display_name | Engineering |
| topics[1].score | 0.9915000200271606 |
| topics[1].domain.id | https://openalex.org/domains/3 |
| topics[1].domain.display_name | Physical Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2204 |
| topics[1].subfield.display_name | Biomedical Engineering |
| topics[1].display_name | Ultrasound and Hyperthermia Applications |
| topics[2].id | https://openalex.org/T10131 |
| topics[2].field.id | https://openalex.org/fields/25 |
| topics[2].field.display_name | Materials Science |
| topics[2].score | 0.982699990272522 |
| topics[2].domain.id | https://openalex.org/domains/3 |
| topics[2].domain.display_name | Physical Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2504 |
| topics[2].subfield.display_name | Electronic, Optical and Magnetic Materials |
| topics[2].display_name | Gold and Silver Nanoparticles Synthesis and Applications |
| funders[0].id | https://openalex.org/F4320313199 |
| funders[0].ror | https://ror.org/03w04rv71 |
| funders[0].display_name | Iran University of Medical Sciences |
| is_xpac | False |
| apc_list.value | 2000 |
| apc_list.currency | EUR |
| apc_list.value_usd | 2200 |
| apc_paid.value | 2000 |
| apc_paid.currency | EUR |
| apc_paid.value_usd | 2200 |
| concepts[0].id | https://openalex.org/C2779949491 |
| concepts[0].level | 2 |
| concepts[0].score | 0.599929928779602 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q242165 |
| concepts[0].display_name | Hyperthermia |
| concepts[1].id | https://openalex.org/C155672457 |
| concepts[1].level | 2 |
| concepts[1].score | 0.5544191002845764 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q61231 |
| concepts[1].display_name | Nanoparticle |
| concepts[2].id | https://openalex.org/C2780192828 |
| concepts[2].level | 3 |
| concepts[2].score | 0.5432785749435425 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q181257 |
| concepts[2].display_name | Prostate cancer |
| concepts[3].id | https://openalex.org/C192562407 |
| concepts[3].level | 0 |
| concepts[3].score | 0.5393585562705994 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q228736 |
| concepts[3].display_name | Materials science |
| concepts[4].id | https://openalex.org/C109316439 |
| concepts[4].level | 3 |
| concepts[4].score | 0.45846402645111084 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q246181 |
| concepts[4].display_name | Cytotoxicity |
| concepts[5].id | https://openalex.org/C53227056 |
| concepts[5].level | 3 |
| concepts[5].score | 0.4559285640716553 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q189152 |
| concepts[5].display_name | Viability assay |
| concepts[6].id | https://openalex.org/C2780783641 |
| concepts[6].level | 3 |
| concepts[6].score | 0.4362516701221466 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q738686 |
| concepts[6].display_name | MTT assay |
| concepts[7].id | https://openalex.org/C87023908 |
| concepts[7].level | 3 |
| concepts[7].score | 0.4344688057899475 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q3870166 |
| concepts[7].display_name | Magnetic nanoparticles |
| concepts[8].id | https://openalex.org/C515602321 |
| concepts[8].level | 2 |
| concepts[8].score | 0.4267391562461853 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q740 |
| concepts[8].display_name | Cobalt |
| concepts[9].id | https://openalex.org/C96232424 |
| concepts[9].level | 3 |
| concepts[9].score | 0.4249183237552643 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q4118072 |
| concepts[9].display_name | Cancer cell |
| concepts[10].id | https://openalex.org/C202751555 |
| concepts[10].level | 2 |
| concepts[10].score | 0.4053579270839691 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q221681 |
| concepts[10].display_name | In vitro |
| concepts[11].id | https://openalex.org/C171250308 |
| concepts[11].level | 1 |
| concepts[11].score | 0.38233107328414917 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q11468 |
| concepts[11].display_name | Nanotechnology |
| concepts[12].id | https://openalex.org/C12554922 |
| concepts[12].level | 1 |
| concepts[12].score | 0.34607994556427 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q7100 |
| concepts[12].display_name | Biophysics |
| concepts[13].id | https://openalex.org/C185592680 |
| concepts[13].level | 0 |
| concepts[13].score | 0.33016258478164673 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q2329 |
| concepts[13].display_name | Chemistry |
| concepts[14].id | https://openalex.org/C71924100 |
| concepts[14].level | 0 |
| concepts[14].score | 0.3262714743614197 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[14].display_name | Medicine |
| concepts[15].id | https://openalex.org/C121608353 |
| concepts[15].level | 2 |
| concepts[15].score | 0.2295306921005249 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q12078 |
| concepts[15].display_name | Cancer |
| concepts[16].id | https://openalex.org/C86803240 |
| concepts[16].level | 0 |
| concepts[16].score | 0.1647486388683319 |
| concepts[16].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[16].display_name | Biology |
| concepts[17].id | https://openalex.org/C126322002 |
| concepts[17].level | 1 |
| concepts[17].score | 0.1534930169582367 |
| concepts[17].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[17].display_name | Internal medicine |
| concepts[18].id | https://openalex.org/C55493867 |
| concepts[18].level | 1 |
| concepts[18].score | 0.12534624338150024 |
| concepts[18].wikidata | https://www.wikidata.org/wiki/Q7094 |
| concepts[18].display_name | Biochemistry |
| concepts[19].id | https://openalex.org/C191897082 |
| concepts[19].level | 1 |
| concepts[19].score | 0.07923394441604614 |
| concepts[19].wikidata | https://www.wikidata.org/wiki/Q11467 |
| concepts[19].display_name | Metallurgy |
| keywords[0].id | https://openalex.org/keywords/hyperthermia |
| keywords[0].score | 0.599929928779602 |
| keywords[0].display_name | Hyperthermia |
| keywords[1].id | https://openalex.org/keywords/nanoparticle |
| keywords[1].score | 0.5544191002845764 |
| keywords[1].display_name | Nanoparticle |
| keywords[2].id | https://openalex.org/keywords/prostate-cancer |
| keywords[2].score | 0.5432785749435425 |
| keywords[2].display_name | Prostate cancer |
| keywords[3].id | https://openalex.org/keywords/materials-science |
| keywords[3].score | 0.5393585562705994 |
| keywords[3].display_name | Materials science |
| keywords[4].id | https://openalex.org/keywords/cytotoxicity |
| keywords[4].score | 0.45846402645111084 |
| keywords[4].display_name | Cytotoxicity |
| keywords[5].id | https://openalex.org/keywords/viability-assay |
| keywords[5].score | 0.4559285640716553 |
| keywords[5].display_name | Viability assay |
| keywords[6].id | https://openalex.org/keywords/mtt-assay |
| keywords[6].score | 0.4362516701221466 |
| keywords[6].display_name | MTT assay |
| keywords[7].id | https://openalex.org/keywords/magnetic-nanoparticles |
| keywords[7].score | 0.4344688057899475 |
| keywords[7].display_name | Magnetic nanoparticles |
| keywords[8].id | https://openalex.org/keywords/cobalt |
| keywords[8].score | 0.4267391562461853 |
| keywords[8].display_name | Cobalt |
| keywords[9].id | https://openalex.org/keywords/cancer-cell |
| keywords[9].score | 0.4249183237552643 |
| keywords[9].display_name | Cancer cell |
| keywords[10].id | https://openalex.org/keywords/in-vitro |
| keywords[10].score | 0.4053579270839691 |
| keywords[10].display_name | In vitro |
| keywords[11].id | https://openalex.org/keywords/nanotechnology |
| keywords[11].score | 0.38233107328414917 |
| keywords[11].display_name | Nanotechnology |
| keywords[12].id | https://openalex.org/keywords/biophysics |
| keywords[12].score | 0.34607994556427 |
| keywords[12].display_name | Biophysics |
| keywords[13].id | https://openalex.org/keywords/chemistry |
| keywords[13].score | 0.33016258478164673 |
| keywords[13].display_name | Chemistry |
| keywords[14].id | https://openalex.org/keywords/medicine |
| keywords[14].score | 0.3262714743614197 |
| keywords[14].display_name | Medicine |
| keywords[15].id | https://openalex.org/keywords/cancer |
| keywords[15].score | 0.2295306921005249 |
| keywords[15].display_name | Cancer |
| keywords[16].id | https://openalex.org/keywords/biology |
| keywords[16].score | 0.1647486388683319 |
| keywords[16].display_name | Biology |
| keywords[17].id | https://openalex.org/keywords/internal-medicine |
| keywords[17].score | 0.1534930169582367 |
| keywords[17].display_name | Internal medicine |
| keywords[18].id | https://openalex.org/keywords/biochemistry |
| keywords[18].score | 0.12534624338150024 |
| keywords[18].display_name | Biochemistry |
| keywords[19].id | https://openalex.org/keywords/metallurgy |
| keywords[19].score | 0.07923394441604614 |
| keywords[19].display_name | Metallurgy |
| language | en |
| locations[0].id | doi:10.1049/2024/8929168 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S97987397 |
| locations[0].source.issn | 1751-8741, 1751-875X |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 1751-8741 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | IET Nanobiotechnology |
| locations[0].source.host_organization | https://openalex.org/P4310311714 |
| locations[0].source.host_organization_name | Institution of Engineering and Technology |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310311714 |
| locations[0].license | cc-by |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | IET Nanobiotechnology |
| locations[0].landing_page_url | https://doi.org/10.1049/2024/8929168 |
| locations[1].id | pmid:39144409 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | IET nanobiotechnology |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/39144409 |
| locations[2].id | pmh:oai:doaj.org/article:d6eb7e7c968849c7ad5c9f81c57d1a8f |
| locations[2].is_oa | False |
| locations[2].source.id | https://openalex.org/S4306401280 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[2].source.host_organization | |
| locations[2].source.host_organization_name | |
| locations[2].source.host_organization_lineage | |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | article |
| locations[2].license_id | |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | IET Nanobiotechnology, Vol 2024 (2024) |
| locations[2].landing_page_url | https://doaj.org/article/d6eb7e7c968849c7ad5c9f81c57d1a8f |
| locations[3].id | pmh:oai:pubmedcentral.nih.gov:11324361 |
| locations[3].is_oa | True |
| locations[3].source.id | https://openalex.org/S2764455111 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | PubMed Central |
| locations[3].source.host_organization | https://openalex.org/I1299303238 |
| locations[3].source.host_organization_name | National Institutes of Health |
| locations[3].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[3].license | other-oa |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | Text |
| locations[3].license_id | https://openalex.org/licenses/other-oa |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | IET Nanobiotechnol |
| locations[3].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/11324361 |
| indexed_in | crossref, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5095869257 |
| authorships[0].author.orcid | |
| authorships[0].author.display_name | Nazanin Oroskhani |
| authorships[0].countries | IR |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I161106909 |
| authorships[0].affiliations[0].raw_affiliation_string | Department of Medical Physics, School of Medicine, Iran University of Medical Sciences, Tehran, Iran |
| authorships[0].affiliations[1].institution_ids | https://openalex.org/I161106909 |
| authorships[0].affiliations[1].raw_affiliation_string | Radiation Biology Research Center, Iran University of Medical Sciences, Tehran, Iran |
| authorships[0].institutions[0].id | https://openalex.org/I161106909 |
| authorships[0].institutions[0].ror | https://ror.org/03w04rv71 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I161106909 |
| authorships[0].institutions[0].country_code | IR |
| authorships[0].institutions[0].display_name | Iran University of Medical Sciences |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Nazanin Oroskhani |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Department of Medical Physics, School of Medicine, Iran University of Medical Sciences, Tehran, Iran, Radiation Biology Research Center, Iran University of Medical Sciences, Tehran, Iran |
| authorships[1].author.id | https://openalex.org/A5020427634 |
| authorships[1].author.orcid | https://orcid.org/0000-0001-6447-9872 |
| authorships[1].author.display_name | Seyed Mohammad Amini |
| authorships[1].countries | IR |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I161106909 |
| authorships[1].affiliations[0].raw_affiliation_string | Radiation Biology Research Center, Iran University of Medical Sciences, Tehran, Iran |
| authorships[1].institutions[0].id | https://openalex.org/I161106909 |
| authorships[1].institutions[0].ror | https://ror.org/03w04rv71 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I161106909 |
| authorships[1].institutions[0].country_code | IR |
| authorships[1].institutions[0].display_name | Iran University of Medical Sciences |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Seyed Mohammad Amini |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Radiation Biology Research Center, Iran University of Medical Sciences, Tehran, Iran |
| authorships[2].author.id | https://openalex.org/A5023690902 |
| authorships[2].author.orcid | https://orcid.org/0000-0003-3213-8824 |
| authorships[2].author.display_name | Sakine Shirvalilou |
| authorships[2].countries | IR |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I161106909 |
| authorships[2].affiliations[0].raw_affiliation_string | Finetech in Medicine Research Center, Iran University of Medical Sciences, Tehran, Iran |
| authorships[2].institutions[0].id | https://openalex.org/I161106909 |
| authorships[2].institutions[0].ror | https://ror.org/03w04rv71 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I161106909 |
| authorships[2].institutions[0].country_code | IR |
| authorships[2].institutions[0].display_name | Iran University of Medical Sciences |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Sakine Shirvalilou |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Finetech in Medicine Research Center, Iran University of Medical Sciences, Tehran, Iran |
| authorships[3].author.id | https://openalex.org/A5111180198 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Mehdi Khodaie |
| authorships[3].countries | IR |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I80543232 |
| authorships[3].affiliations[0].raw_affiliation_string | Materials Science and Engineering, K. N. Toosi University of Technology, Tehran, Iran |
| authorships[3].institutions[0].id | https://openalex.org/I80543232 |
| authorships[3].institutions[0].ror | https://ror.org/0433abe34 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I80543232 |
| authorships[3].institutions[0].country_code | IR |
| authorships[3].institutions[0].display_name | K.N.Toosi University of Technology |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Mehdi Khodaie |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Materials Science and Engineering, K. N. Toosi University of Technology, Tehran, Iran |
| authorships[4].author.id | https://openalex.org/A5012690210 |
| authorships[4].author.orcid | https://orcid.org/0000-0003-1973-2140 |
| authorships[4].author.display_name | Seied Rabi Mahdavi |
| authorships[4].countries | IR |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I161106909 |
| authorships[4].affiliations[0].raw_affiliation_string | Radiation Biology Research Center, Iran University of Medical Sciences, Tehran, Iran |
| authorships[4].affiliations[1].institution_ids | https://openalex.org/I161106909 |
| authorships[4].affiliations[1].raw_affiliation_string | Department of Medical Physics, School of Medicine, Iran University of Medical Sciences, Tehran, Iran |
| authorships[4].institutions[0].id | https://openalex.org/I161106909 |
| authorships[4].institutions[0].ror | https://ror.org/03w04rv71 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I161106909 |
| authorships[4].institutions[0].country_code | IR |
| authorships[4].institutions[0].display_name | Iran University of Medical Sciences |
| authorships[4].author_position | last |
| authorships[4].raw_author_name | Seyed Rabi Mahdavi |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Department of Medical Physics, School of Medicine, Iran University of Medical Sciences, Tehran, Iran, Radiation Biology Research Center, Iran University of Medical Sciences, Tehran, Iran |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1049/2024/8929168 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Anti‐Proliferative Activity of Poloxamer Cobalt Ferrite Nanoparticles against Human Prostate Cancer (DU‐145) Cells: In‐Vitro Study |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10063 |
| primary_topic.field.id | https://openalex.org/fields/25 |
| primary_topic.field.display_name | Materials Science |
| primary_topic.score | 0.9983999729156494 |
| primary_topic.domain.id | https://openalex.org/domains/3 |
| primary_topic.domain.display_name | Physical Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2502 |
| primary_topic.subfield.display_name | Biomaterials |
| primary_topic.display_name | Nanoparticle-Based Drug Delivery |
| related_works | https://openalex.org/W2341333145, https://openalex.org/W3030667680, https://openalex.org/W574198516, https://openalex.org/W2321931350, https://openalex.org/W60177492, https://openalex.org/W2389310297, https://openalex.org/W4387804390, https://openalex.org/W2961705167, https://openalex.org/W2079454806, https://openalex.org/W2791767507 |
| cited_by_count | 14 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 9 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 5 |
| locations_count | 4 |
| best_oa_location.id | doi:10.1049/2024/8929168 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S97987397 |
| best_oa_location.source.issn | 1751-8741, 1751-875X |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 1751-8741 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | IET Nanobiotechnology |
| best_oa_location.source.host_organization | https://openalex.org/P4310311714 |
| best_oa_location.source.host_organization_name | Institution of Engineering and Technology |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310311714 |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | IET Nanobiotechnology |
| best_oa_location.landing_page_url | https://doi.org/10.1049/2024/8929168 |
| primary_location.id | doi:10.1049/2024/8929168 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S97987397 |
| primary_location.source.issn | 1751-8741, 1751-875X |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 1751-8741 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | IET Nanobiotechnology |
| primary_location.source.host_organization | https://openalex.org/P4310311714 |
| primary_location.source.host_organization_name | Institution of Engineering and Technology |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310311714 |
| primary_location.license | cc-by |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | IET Nanobiotechnology |
| primary_location.landing_page_url | https://doi.org/10.1049/2024/8929168 |
| publication_date | 2024-01-01 |
| publication_year | 2024 |
| referenced_works | https://openalex.org/W4360806511, https://openalex.org/W3138539949, https://openalex.org/W2989613213, https://openalex.org/W2599907051, https://openalex.org/W4366603600, https://openalex.org/W4294898161, https://openalex.org/W2898105459, https://openalex.org/W2898728348, https://openalex.org/W4220690386, https://openalex.org/W2028661131, https://openalex.org/W1973220676, https://openalex.org/W3021442462, https://openalex.org/W4281787787, https://openalex.org/W3013680909, https://openalex.org/W3193587623, https://openalex.org/W3098846716, https://openalex.org/W2755535320, https://openalex.org/W2476529906, https://openalex.org/W2013594472, https://openalex.org/W2007631334, https://openalex.org/W3093989404, https://openalex.org/W2047012720, https://openalex.org/W3095073395, https://openalex.org/W3131615262, https://openalex.org/W4213424400, https://openalex.org/W4379508260, https://openalex.org/W2995226295, https://openalex.org/W4226063019, https://openalex.org/W2922452306, https://openalex.org/W2001591766, https://openalex.org/W2884188695, https://openalex.org/W3173321905, https://openalex.org/W4310895038, https://openalex.org/W2761230819, https://openalex.org/W4220862765, https://openalex.org/W3174942452, https://openalex.org/W2937540903, https://openalex.org/W2081788608, https://openalex.org/W3088275628, https://openalex.org/W4232370837 |
| referenced_works_count | 40 |
| abstract_inverted_index.a | 26, 39, 107, 171 |
| abstract_inverted_index.15 | 128 |
| abstract_inverted_index.4% | 148 |
| abstract_inverted_index.as | 25 |
| abstract_inverted_index.at | 166 |
| abstract_inverted_index.in | 11, 85, 173 |
| abstract_inverted_index.is | 2 |
| abstract_inverted_index.of | 8, 21, 32, 53, 63, 69, 104, 109, 116, 143, 149 |
| abstract_inverted_index.on | 76, 156, 177 |
| abstract_inverted_index.or | 84, 132, 190 |
| abstract_inverted_index.to | 16, 182 |
| abstract_inverted_index.± | 111, 125, 147 |
| abstract_inverted_index.2.6 | 112 |
| abstract_inverted_index.5.5 | 110 |
| abstract_inverted_index.53% | 146 |
| abstract_inverted_index.MTT | 92 |
| abstract_inverted_index.The | 45, 67, 114 |
| abstract_inverted_index.and | 61, 73, 91 |
| abstract_inverted_index.for | 29, 50 |
| abstract_inverted_index.new | 27 |
| abstract_inverted_index.nm. | 113 |
| abstract_inverted_index.not | 135 |
| abstract_inverted_index.the | 3, 17, 51, 58, 70, 101, 141 |
| abstract_inverted_index.was | 48, 81, 154 |
| abstract_inverted_index.This | 13 |
| abstract_inverted_index.cell | 137 |
| abstract_inverted_index.have | 134 |
| abstract_inverted_index.men. | 12 |
| abstract_inverted_index.min. | 129 |
| abstract_inverted_index.most | 5 |
| abstract_inverted_index.size | 108 |
| abstract_inverted_index.that | 169, 184 |
| abstract_inverted_index.them | 144 |
| abstract_inverted_index.type | 7 |
| abstract_inverted_index.were | 65, 185 |
| abstract_inverted_index.with | 87, 106, 119, 162, 188, 191 |
| abstract_inverted_index.(TEM) | 99 |
| abstract_inverted_index.42.73 | 124 |
| abstract_inverted_index.Then, | 57 |
| abstract_inverted_index.after | 127 |
| abstract_inverted_index.alone | 187 |
| abstract_inverted_index.assay | 180 |
| abstract_inverted_index.based | 176 |
| abstract_inverted_index.cells | 37, 80, 117, 160, 183 |
| abstract_inverted_index.death | 10 |
| abstract_inverted_index.field | 43 |
| abstract_inverted_index.human | 34, 157 |
| abstract_inverted_index.novel | 18 |
| abstract_inverted_index.radio | 40 |
| abstract_inverted_index.size, | 60 |
| abstract_inverted_index.study | 14 |
| abstract_inverted_index.under | 38, 121 |
| abstract_inverted_index.0.2°C | 126 |
| abstract_inverted_index.assay. | 95 |
| abstract_inverted_index.cancer | 1, 9, 79, 159 |
| abstract_inverted_index.cells. | 151 |
| abstract_inverted_index.cobalt | 23, 54, 163 |
| abstract_inverted_index.colony | 88, 178 |
| abstract_inverted_index.method | 47 |
| abstract_inverted_index.refers | 15 |
| abstract_inverted_index.second | 4 |
| abstract_inverted_index.RF‐MF | 74, 122, 130 |
| abstract_inverted_index.applied | 49 |
| abstract_inverted_index.ferrite | 24, 55, 164 |
| abstract_inverted_index.methods | 90 |
| abstract_inverted_index.reached | 123 |
| abstract_inverted_index.thermal | 30 |
| abstract_inverted_index.treated | 118, 186 |
| abstract_inverted_index.Bromide] | 94 |
| abstract_inverted_index.DU‐145 | 33, 77 |
| abstract_inverted_index.However, | 140 |
| abstract_inverted_index.Prostate | 0 |
| abstract_inverted_index.RF‐MF. | 192 |
| abstract_inverted_index.affected | 136 |
| abstract_inverted_index.approach | 28 |
| abstract_inverted_index.compared | 181 |
| abstract_inverted_index.decrease | 172 |
| abstract_inverted_index.electron | 97 |
| abstract_inverted_index.exposure | 75 |
| abstract_inverted_index.fraction | 175 |
| abstract_inverted_index.frequent | 6 |
| abstract_inverted_index.magnetic | 42 |
| abstract_inverted_index.prostate | 35, 78, 158 |
| abstract_inverted_index.specific | 167 |
| abstract_inverted_index.survival | 174 |
| abstract_inverted_index.cancerous | 36, 150 |
| abstract_inverted_index.confirmed | 100 |
| abstract_inverted_index.formation | 89, 179 |
| abstract_inverted_index.frequency | 41 |
| abstract_inverted_index.performed | 155 |
| abstract_inverted_index.spherical | 102 |
| abstract_inverted_index.synthesis | 52 |
| abstract_inverted_index.treatment | 131 |
| abstract_inverted_index.viability | 138 |
| abstract_inverted_index.(DU‐145) | 161 |
| abstract_inverted_index.(RF‐MF). | 44 |
| abstract_inverted_index.In‐vitro | 152 |
| abstract_inverted_index.eradicated | 145 |
| abstract_inverted_index.microscopy | 98 |
| abstract_inverted_index.morphology | 62, 103 |
| abstract_inverted_index.separately | 83 |
| abstract_inverted_index.structure, | 59 |
| abstract_inverted_index.application | 20 |
| abstract_inverted_index.combination | 86, 142 |
| abstract_inverted_index.eradication | 31 |
| abstract_inverted_index.synthesized | 71 |
| abstract_inverted_index.temperature | 115 |
| abstract_inverted_index.Transmission | 96 |
| abstract_inverted_index.cytotoxicity | 68 |
| abstract_inverted_index.demonstrated | 170 |
| abstract_inverted_index.hydrothermal | 46 |
| abstract_inverted_index.hyperthermia | 19, 153 |
| abstract_inverted_index.investigated | 82 |
| abstract_inverted_index.nanoparticle | 64 |
| abstract_inverted_index.nanoparticles | 72, 105, 120, 133, 165, 189 |
| abstract_inverted_index.characterized. | 66 |
| abstract_inverted_index.concentrations | 168 |
| abstract_inverted_index.nanoparticles. | 56 |
| abstract_inverted_index.significantly. | 139 |
| abstract_inverted_index.poloxamer‐coated | 22 |
| abstract_inverted_index.[3‐(4,5‐Dimethylthiazol‐2‐yl)‐2,5‐Diphenyltetrazolium | 93 |
| cited_by_percentile_year.max | 99 |
| cited_by_percentile_year.min | 98 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 5 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.6100000143051147 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.9194011 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | True |